WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2018067618) HPV-SPECIFIC BINDING MOLECULES
Latest bibliographic data on file with the International Bureau    Submit observation

Pub. No.: WO/2018/067618 International Application No.: PCT/US2017/055005
Publication Date: 12.04.2018 International Filing Date: 03.10.2017
IPC:
C07K 14/725 (2006.01)
Applicants: JUNO THERAPEUTICS, INC.[US/US]; 400 Dexter Ave. N, Suite 1200 Seattle, WA 98109, US
Inventors: SISSONS, James; US
BRANDT, Cameron; US
CROFT, Alexandra; US
EBENS, Allen; US
PEPER, Haley; US
TOY, Dean, Y.; US
BELMONT, Brian; US
GOLDFLESS, Stephen; US
JIANG, Yue; US
JOHNSTONE, Timothy; US
KOPPSTEIN, David; US
NGUYEN, Hieu; US
SATHER, Blythe; US
TIMBERLAKE, Sonia; US
Agent: POTTER, Karen; US
AHN, Sejin; US
BANKO, Max; US
ARJOMAND, Mehran; US
AIKEN, Charity; US
Priority Data:
62/403,66103.10.2016US
Title (EN) HPV-SPECIFIC BINDING MOLECULES
(FR) MOLÉCULES SE LIANT SPÉCIFIQUEMENT AU VPH
Abstract: front page image
(EN) Provided are binding molecules, such as TCRs or antigen binding fragments thereof and antibodies and antigen-binding fragments thereof, such as those that recognize or bind human papilloma virus (HPV) 16, including HPV 16 E6 and HPV 16 E7. Also provided are engineered cells containing such binding molecules, compositions containing the binding molecules or engineered cells, and methods of treatment, such as administration of the binding molecules, engineered cells, or compositions.
(FR) L'invention concerne des molécules de liaison, telles que des TCR ou fragments de ceux-ci se liant à l'antigène et des anticorps et fragments de ceux-ci se liant à l'antigène, tels que ceux qui reconnaissent ou se lient au virus du papillome humain (VPH) 16, y compris au VPH16 E6 et au VPH 16 E7. Des cellules génétiquement modifiées contenant lesdites molécules de liaison, des compositions contenant lesdites molécules de liaison ou cellules génétiquement modifiées, et des méthodes de traitement, par exemple, par administration desdites molécules de liaison, cellules génétiquement modifiées, ou compositions, sont en outre décrites.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (EPO) (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)